Sign up for our pop-up newsletter: ESMO in 30 Seconds

STAT's Andrew Joseph shares key developments emerging from this leading oncology conference straight to your inbox from 

Log In    STAT+ Credit name / STAT YOUR GUIDE TO THE 2024 ESMO CONGRESS Receive daily updates on September 13, 14, and 16! Stay on top of the key panels and presentations on emerging data and transformative therapies with our pop-up newsletter covering the European Society for Medical Oncology 2024 congress, ESMO in 30 seconds.   Receive Andrew Joseph's insight in his daily roundup of the biggest stories from the weekend sent straight to your inbox. sign up now STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us

FDA approves new tool in fight against mpox

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Approves Emergent BioSolutions Vaccine as New Tool in Fight Against Mpox Emergent BioSolutions' smallpox vaccine, ACAM2000, now has an additional FDA approval covering mpox. It's one of two FDA-approved mpox vaccines, joining Jynneos from Bavarian Nordic.

Featured News

Healthcare Moves: A Monthly Summary of Hires and Layoffs Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry. Mental Healthcare in Underserved Populations is in Crisis and It's Not Just a Provider Resource Problem Expanding the diversity of our mental health workforce is crucial, but it's a long-term goal that won't address the immediate needs we're facing today. We need solutions now to bridge the gap between demand and access. Hinge Health, Midi Health Strike Partnership for Women Experiencing Menopause Through a new partnership, Hinge Health members receiving movement-based menopause support will also be able to access clinical care from Midi Health. StartUPDATES: New Developments from Healthcare Startups Check out news from Oral Genome, BeMe Health, Noetik, and Vouched. MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Graham Barnes, CEO of Medically Home In this month's episode, Senior Reporter Katie Adams explored some of the executive moves and layoffs that recently occurred in the healthcare world. She also interviewed Graham Barnes, who just stepped into a new role as the CEO of Medically Home. Overcoming the Challenges of Integrating AI in Care Management  Providers should carefully evaluate how different AI models can be strategically integrated to optimize the care management lifecycle and address the complex needs of their patients and populations, while at the same time prioritizing patient safety and ethical considerations.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Graham Barnes, CEO of Medically Home In this month's episode, Senior Reporter Katie Adams explored some of the executive moves and layoffs that recently occurred in the healthcare world. She also interviewed Graham Barnes, who just stepped into a new role as the CEO of Medically Home. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe

UnitedHealth bought the medical group. Doctors and patients paid the price

Plus: The Biden administration had a plan for the next pandemic. It's fizzling out.

August 31, 2024 Check out STAT+

Sponsored By

Hey — for a special STAT+ discount, use the code LABORDAY to get 25% your first year of our premium membership. Don't miss out.

UnitedHealth pledged a hands-off approach after buying a Connecticut medical group. Then it upended how doctors practice On paper, it looked like control of ProHealth's offices would remain in the hands of physicians, even after UnitedHealth bought the practice. In reality, the primary care network is a shell of its former self — with doctors and patients alike leaving in droves. Read more. By Lizzy Lawrence, Casey Ross, Bob Herman, and Tara Bannow

---

---

Karen Dias for STAT Exclusive: Biden administration's $3.2 billion antiviral pandemic plan is fizzling out The Antiviral Program for Pandemics aimed to protect Americans from the mistakes of the Covid-19 outbreak. But funding is slated to run out on April 30 with little to show for it. What went wrong? Read more. By Jason Mast Dexcom Continuous glucose monitoring for the masses is here. Are we ready for it? Over the past 25 years, continuous glucose monitors have changed the shape of diabetes care. Now they're about to become dramatically more accessible — depending on how clinicians and consumers decide to use them. Read more. By Lizzy Lawrence More great reads from STAT this week Eli Lilly's lauded discount of its obesity drug Zepbound comes with caveats. Some will benefit. But not all. Hims & Hers has supercharged its business by offering compounded versions of GLP-1 weight loss drugs — but legal challenges could soon bring the party to an end. Thoughts, takes, and burning biotech questions as the beginning of the end of the year approaches, according to senior correspondent Adam Feuerstein.

---

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser